Premedication of hemin for eradication therapy of Helicobacter pylori in patients with porphyria

Tadayuki Takata; Yohei Kokudo; Asahiro Morishita; Kodai Kume; Tatsuo Yachida; Masaki Kamada; Hideki Kobara; Kazushi Deguchi; Tetsuo Touge; Hisashi Masugata; Tsutomu Masaki

doi:10.1002/ccr3.3715

Premedication of hemin for eradication therapy of Helicobacter pylori in patients with porphyria

Clin Case Rep. 2020 Dec 26;9(2):944-946. doi: 10.1002/ccr3.3715. eCollection 2021 Feb.

Authors

Affiliations

¹ Department of General Internal Medicine Kagawa University Faculty of Medicine Miki Japan.
² Department of Neurology Kagawa University Faculty of Medicine Miki Japan.
³ Department of Intractable Neurological Research Faculty of Medicine Kagawa University Miki Japan.
⁴ Department of Gastroenterology Kagawa University Faculty of Medicine Miki Japan.
⁵ Department of Health Sciences Kagawa University Faculty of Medicine Miki Japan.

Abstract

Eradication therapy of Helicobacter pylori may be safe if hemin has been intravenously administered in advance, even in patients with a history of recurrent acute porphyria attack.

Keywords: Helicobacter pylori; hemin; porphyria.

Publication types

Case Reports